NCT06428253View on ClinicalTrials.gov

Efficacy and Safety of HMM1-022 in Temporary Correction of Crow's Feet

NARecruitingINTERVENTIONAL
Enrollment

171

Participants

Timeline

Start Date

May 14, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions
Crow's Feet
Interventions
DEVICE

HMM1-022

intradermal injection

Trial Locations (1)

06973

RECRUITING

Chung-Ang University Hospital, Seoul

All Listed Sponsors
lead

Humedix Co., Ltd.

INDUSTRY